Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance

被引：0

作者：

Geoffrey Martinage

Angela M. Hong

Mike Fay

Thanuja Thachil

Daniel Roos

Narelle Williams

Serigne Lo

Gerald Fogarty

机构：

[1] Melanoma Institute Australia,Central Clinical School

[2] The University of Sydney,undefined

[3] Centre Oscar-Lambret,undefined

[4] Mater Hospital,undefined

[5] GenesisCare,undefined

[6] Radiation Oncology,undefined

[7] Mater Hospital,undefined

[8] The University of Sydney,undefined

[9] School of Medicine and Public Health,undefined

[10] University of Newcastle,undefined

[11] GenesisCare,undefined

[12] Radiation Oncology,undefined

[13] Northern Territory Radiation Oncology,undefined

[14] Alan Walker Cancer Care Centre,undefined

[15] Royal Adelaide Hospital,undefined

[16] University of Adelaide,undefined

[17] Australia and New Zealand Melanoma Trials Group,undefined

来源：

Radiation Oncology | / 13卷

关键词：

Radiotherapy; Whole brain radiotherapy; Trial; Quality assurance; Intensity-modulated radiotherapy; Hippocampal avoidance;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

共 50 条

[31] Randomized Trial of Whole-Brain Radiation Therapy in Melanoma Brain Metastases: First Interim Analysis
Fogarty, G. B.
Hong, A.
Dolven-Jacobsen, K.
Reisse, C. H.
Burmeister, B.
Steel, V.
Haydu, L.
Dhillon, H.
Shivalingham, B.
Drummond, K.
Vardy, J.
Nowak, A.
Hruby, G.
Scolyer, R.
Mandel, C.
Thompson, J. F.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S313 - S314
[32] Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial (vol 23, pg 478, 2021)
Yang, Wen-Chi
Chen, Ya-Fang
Yang, Chi-Cheng
Wu, Pei-Fang
Chan, Hsing-Min
Chen, Jenny Ling-Yu
Chen, Guann-Yiing
Cheng, Jason Chia-Hsien
Kuo, Sung-Hsin
Hsu, Feng-Ming
NEURO-ONCOLOGY, 2021, 23 (12) : 2125 - 2125
[33] Accrual to a Randomised Trial of Whole Brain Radiotherapy in Melanoma Brain Metastases is Feasible.
Fogarty, G.
Hong, A.
Dolven, K.
Shivalingham, B.
Burmeister, B.
Haydu, L.
Paton, E.
Thompson, J.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 57 - 57
[34] Analysis of Radiotherapy Quality Assurance Data for the Convert Trial - Does Non-Compliance to Protocol Affect Survival?
Groom, N.
Wilson, E.
Faivre-Finn, C.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1745 - S1745
[35] Dosimetric feasibility of hippocampal avoidance whole brain radiotherapy with an MRI-guided linear accelerator
Graham, Jasmine A.
Redler, Gage
Delozier, Kirby B.
Yu, Hsiang-Hsuan Michael
Oliver, Daniel E.
Rosenberg, Stephen A.
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2022, 23 (06):
[36] The Dosimetric Study of Hippocampal-Avoidance Whole Brain Radiotherapy with Intensity Modulated Proton Therapy
Sun, T.
Lin, X.
Yin, Y.
MEDICAL PHYSICS, 2020, 47 (06) : E859 - E859
[37] Is Hippocampal Avoidance during Whole Brain Radiotherapy Risky for Small Cell Lung Cancer Patients?
Kirakli, Esra
Oztekin, Ozgur
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S409 - S409
[38] Perihippocampal failure after hippocampal-avoidance whole-brain radiotherapy in cancer patients with brain metastases Results of a retrospective analysis
Li-Tsun Shieh
Sung-Wei Lee
Chia-Chun Chen
Yi-Chia Ho
Yu-Wen Wang
Sheng-Yow Ho
MEDICINE, 2022, 101 (14)
[39] Volumetric Analysis of Hippocampal Atrophy after Hippocampal-Sparing Whole Brain Radiotherapy
Popp, I.
Kaller, C.
Rau, A.
Kellner, E.
Reisert, M.
Fennell, J.
Rothe, T.
Nieder, C.
Urbach, H.
Egger, K.
Grosu, A. -L.
STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S51 - S51
[40] Automated Planning and Delivery of Hippocampal Avoidance Whole-Brain Radiotherapy for Brain Metastases Using HyperArc Technology
Rusu, I.
Conrad, B.
Steber, J.
Solanki, A.
Melian, E.
Roeske, J.
MEDICAL PHYSICS, 2019, 46 (06) : E438 - E438

← 1 2 3 4 5 →